What is the recommended pediatric dosage of methylprednisolone, including intravenous dosing (dose per kilogram, infusion schedule, maximum dose) and subsequent oral prednisone taper?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediatric Methylprednisolone Dosing

For pediatric patients, methylprednisolone IV dosing ranges from 0.11-1.6 mg/kg/day for standard indications, but in severe inflammatory conditions requiring intensification therapy (such as MIS-C or IVIG-resistant Kawasaki disease), use 10-30 mg/kg/day IV, with a maximum single dose of 30 mg/kg infused over at least 30 minutes. 1

Standard Dosing Parameters

The FDA-approved pediatric dosing framework provides:

  • Initial dose range: 0.11-1.6 mg/kg/day divided into 3-4 doses (equivalent to 3.2-48 mg/m²/day) 1
  • Minimum dose: Should not be less than 0.5 mg/kg every 24 hours 1
  • Infusion rate for high-dose therapy: Administer 30 mg/kg over at least 30 minutes to avoid cardiac arrhythmias 1

Disease-Specific Protocols

For Multisystem Inflammatory Syndrome in Children (MIS-C)

First-line therapy: 1-2 mg/kg/day IV methylprednisolone combined with IVIG 2

Intensification therapy (for refractory disease with persistent fever or significant organ involvement): 10-30 mg/kg/day IV methylprednisolone 2

This represents the most current guideline-based approach (2021) for severe pediatric inflammatory conditions.

For IVIG-Resistant Kawasaki Disease

Pulse dosing: 30 mg/kg/day IV for 3 consecutive days, followed by oral prednisolone taper 3

  • Initial oral dose: 2 mg/kg/day prednisolone
  • Taper over 2 weeks after CRP normalizes 3

Important caveat: The 30 mg/kg/day pulse regimen showed comparable efficacy to repeat IVIG in Japanese studies, though fever recurrence was slightly more common with pulse steroids 3.

For Asthma Exacerbations

NHLBI-recommended dosing: 1-2 mg/kg/day in single or divided doses 1

  • Continue "burst" therapy for 3-10 days until peak expiratory flow reaches 80% of personal best
  • No need to taper after short courses 1

Infusion Schedule and Administration

High-dose therapy (>0.5 g): Must infuse over at least 10 minutes to prevent cardiac complications 1

Standard doses: Can be administered IV push over several minutes 1

Frequency: High-dose pulses (30 mg/kg) may be repeated every 4-6 hours for up to 48 hours in life-threatening situations 1

Oral Prednisone Taper

After IV methylprednisolone pulse therapy:

  • Kawasaki disease protocol: Start oral prednisolone at 2 mg/kg/day, taper over 2 weeks after inflammation resolves 3
  • General principle: Gradual withdrawal is essential when therapy exceeds a few days 1
  • Conversion: 4 mg methylprednisolone = 5 mg prednisone 1

Critical Safety Considerations

Cardiac monitoring: Rapid infusion of doses >0.5 g over <10 minutes has caused arrhythmias and cardiac arrest 1. Always infuse high doses over at least 30 minutes.

Benzyl alcohol warning: The reconstitution solution contains benzyl alcohol, which has been associated with gasping syndrome in neonates 1. Use caution in very young infants.

Dose individualization: While the FDA label emphasizes individualization, the evidence supports starting at the higher end of the dosing range (1-2 mg/kg/day) for moderate-severe disease, escalating to 10-30 mg/kg/day for refractory cases 2, 1.

Maximum Dose Considerations

While no absolute maximum is specified in pediatric guidelines, the practical ceiling is 30 mg/kg/dose based on the MIS-C and Kawasaki disease literature 2, 3. This can be repeated every 4-6 hours for up to 48-72 hours in life-threatening situations 1.

Clinical pearl: Recent pediatric critical asthma data suggests that conservative dosing (≤0.5 mg/kg/dose every 6 hours) may achieve similar outcomes to standard dosing (>0.5 mg/kg/dose) with potentially shorter PICU stays 4, though this requires prospective validation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.